APR 27, 2016 08:46 AM PDT

Autoimmune Encephalitis Mimics Effect of "Angel Dust"

WRITTEN BY: Kara Marker
Originally developed as an anesthetic in 1926, phencyclidine (PCP), also known as “angel dust,” was discontinued in 1965 when patients receiving the drug reported feeling delusional, anxious, and agitated. Soon after PCP emerged as an abused substance, and it is now present in many illegal drugs. Almost a century later, scientists discovered an autoimmune disease called autoimmune encephalitis (AE) which strangely has many of the same effects on the brain as PCP.
 
Like PCP, AE disrupts the function of a neurotransmitter called glutamate, specifically the NMDA receptor. A schedule II controlled substance, PCP causes feelings of detachment from the environment and self, while anti-NMDA AE produced schizophrenia-like symptoms: behavioral changes, psychosis, memory loss, and decreased levels of consciousness.
 
"Angel Dust"
 
In a new study published in Biological Psychiatry, scientific experts looked at AE patients recovering from the acute phase of the disease, testing their memory and looking for structural damage in the hippocampus, the part of the brain strongly associated with memory.
 
Multimodal magnetic resonance imaging (MRI) data from the 40 recovering AE patients showed several destruction of hippocampal microstructural integrity, as compared to 25 healthy control subjects. Decreased hippocampal volumes observed from the data was directly correlated to patients’ memory performance, severity of disease, and duration of disease.
 
Scientists and doctors agree that treating anti-NMDA AE quickly and aggressively is of utmost importance, because any behavioral symptoms that arise imply that autoantibodies are attacking hippocampal tissues. Unfortunately, the disease is incredibly difficult to diagnose.
 
MRI in Encephalitis. Areas of increased signal intensity are noted in the hippocampi. The right side is slightly thickened.
 
"[The behavioral symptoms] may be easily misdiagnosed as the psychiatric disorders that they superficially resemble,” explained Biological Psychiatry Editor Dr. John Krystal.
 
“Early and aggressive treatment of AE leads to the best outcomes,” experts from the Autoimmune Encephalitis Alliance (AEA) added.
 
Additionally, AE diagnosis requires “collaboration among multiple medical disciplines,” as described by the AEA, with neurologists, rheumatologists, psychiatrists, and immunologists among some of the professionals needed.
 
A few treatment options exist for fortunate patients who receive an early diagnosis of one of the 13 known types of AE:
  • Removal of teratoma (if present) that could be triggering autoimmune response
  • Anti-inflammatory drugs
  • Plasmapheresis to remove autoantibodies
  • Intravenous immunoglobulin – occupies binding sites so harmful antibodies cannot attack brain tissue
Increased understanding of the disease progression from this study is also encouraging scientists to find more ways to better diagnose AE as early as possible, with advanced imagine protocols the first technology scientists plan to explore.
 
 
Source: Elsevier, Autoimmune Encephalitis Alliance,  Center for Substance Abuse Research at the University of Maryland
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 28, 2018
Immunology
JUL 28, 2018
IgM Antibody Protects against HIV-1 Infection
The antibody IgM is shown to be provide protection against HIV infection in rhesus monkeys up to 82 days past exposure to HIV....
AUG 13, 2018
Immunology
AUG 13, 2018
Silent Viruses Impact Microbe and Immune Cell Populations
Subclinical infections may alter the immune system and gut microbiota in the human host impacting how we respond to environmental stimuli like vaccines....
SEP 26, 2018
Immunology
SEP 26, 2018
What Superbug? A New Antibiotic Contender
Scientists from a biotechnology corporation, Genentech, have altered a protein that blocks a signaling pathway in gram-negative bacteria to engineer a new antibiotic, currently called G0775,...
OCT 29, 2018
Immunology
OCT 29, 2018
Immunity for All
A study published in Nature has shed light on the evolution of immune system genes across species with great detail at the single-cell level...
OCT 31, 2018
Immunology
OCT 31, 2018
Blood Clot Reduction
Vaccine developments to reduce blood clotting in stroke patients...
NOV 13, 2018
Immunology
NOV 13, 2018
Bacteria Offers Solution to Inflammation
A team of researchers surveys the mutualistic relationship between gut bacteria and host in regards to gut inflammation in zebrafish...
Loading Comments...